無料プレビュー

AstraZeneca PLC (AZN) · New York Stock Exchange

プロフィール

AstraZeneca is a global innovation-driven biopharmaceutical company that discovers, develops, and commercializes prescription medicines across oncology, cardiovascular-renal-metabolic disease, respiratory & immunology, vaccines & immune therapies, and rare disease. The company markets branded pharmaceutical products directly to customers worldwide and maintains an extensive pipeline of clinical-stage candidates. AstraZeneca operates through five reportable segments corresponding to its primary therapeutic areas, with significant geographic presence in the United States, Europe, China, and othe

主要指標

株価: $158.78 (-0.84%)
時価総額: 2,462億ドル
PER（今期予想）: 15.5
PBR: 4.9
配当利回り: 2.03%
52週レンジ: $153.41 – $212.71
業種: Healthcare / Drug Manufacturers - General
上場: New York Stock Exchange
構成銘柄: —

比較会社: LLY Eli Lilly and Company、JNJ Johnson & Johnson、ABBV AbbVie Inc.、MRK Merck & Co., Inc.、NVS Novartis AG、AMGN Amgen Inc.、GILD Gilead Sciences, Inc.、NVO Novo Nordisk A/S

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-30 · 更新: 2026-10-09